Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,095 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Irinotecan- vs. Oxaliplatin-Based Doublets in KRASG12C-Mutated Metastatic Colorectal Cancer-A Multicentre Propensity-Score-Matched Retrospective Analysis.
Formica V, Morelli C, Conca V, Calegari MA, Lucchetti J, Dell'Aquila E, Schirripa M, Messina M, Salvatore L, Lo Prinzi F, Dima G, Trovato G, Riondino S, Roselli M, Skoulidis F, Arkenau HT, Cremolini C. Formica V, et al. Among authors: messina m. Cancers (Basel). 2023 Jun 5;15(11):3064. doi: 10.3390/cancers15113064. Cancers (Basel). 2023. PMID: 37297026 Free PMC article.
Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the "CARACAS" study.
Prete AA, Manca P, Messina M, Formica V, Frassineti GL, Zampino MG, Corsi DC, Orciuolo C, Prisciandaro M, Bergamo F, Angerilli V, Scartozzi M, Casagrande M, Masi G, Ronzoni M, Morano F, Vettore V, Salmaso R, Rasola C, Maddalena G, Del Bianco P, Milione M, Cremolini C, Fassan M, Pietrantonio F, Lonardi S. Prete AA, et al. Among authors: messina m. Eur J Cancer. 2023 Mar;182:87-97. doi: 10.1016/j.ejca.2022.12.025. Epub 2023 Jan 9. Eur J Cancer. 2023. PMID: 36753836 Free article. Clinical Trial.
Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab.
Damassi A, Cremante M, Signori A, Rebuzzi SE, Malgeri A, Napoli MD, Caffo O, Vignani F, Cavo A, Roviello G, Prati V, Tudini M, Atzori F, Messina M, Morelli F, Prati G, Nolè F, Catalano F, Murianni V, Rescigno P, Banna GL, Fornarini G, Buti S. Damassi A, et al. Among authors: messina m. Immunotherapy. 2024;16(18-19):1095-1103. doi: 10.1080/1750743X.2024.2385881. Epub 2024 Aug 19. Immunotherapy. 2024. PMID: 39155821
Prostate-specific membrane antigen-PET/CT may result in stage migration in prostate cancer: performances, quantitative analysis, and potential criticism in the clinical practice.
Alongi P, Messina M, Pepe A, Arnone A, Vultaggio V, Longo C, Fiasconaro E, Mirabile A, Ricapito R, Blasi L, Arnone G, Messina C. Alongi P, et al. Among authors: messina c, messina m. Nucl Med Commun. 2024 Jul 1;45(7):622-628. doi: 10.1097/MNM.0000000000001850. Epub 2024 Apr 27. Nucl Med Commun. 2024. PMID: 38835182
Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study.
Messina C, Catalano M, Roviello G, Gandini A, Maruzzo M, De Giorgi U, Pedrazzoli P, Sbrana A, Zucal PA, Masini C, Naglieri E, Procopio G, Milella M, Catalano F, Fratino L, Pipitone S, Ricotta R, Panni S, Mollica V, Soraru M, Prati V, Atzori F, Di Napoli M, Messina M, Morelli F, Prati G, Nole F, Malgeri A, Tudini M, Vignani F, Cavo A, Signori A, Banna GL, Rescigno P, Buti S, Rebuzzi SE, Fornarini G. Messina C, et al. Among authors: messina m. Cancer Immunol Immunother. 2024 Jul 2;73(9):161. doi: 10.1007/s00262-024-03741-2. Cancer Immunol Immunother. 2024. PMID: 38954006 Free PMC article.
Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25).
Gambale E, Maruzzo M, Messina C, De Gennaro Aquino I, Vascotto IA, Rossi V, Bimbatti D, Cavasin N, Messina M, Mennitto A, Rebuzzi SE, Nasso C, Mercinelli C, Maiorano BA, Fanelli M, Sorarù M, Scolari F, Mela MM, Galli L, Salfi A, Rizzo M, Puglisi S, Orlando V, Fornarini G, Rametta A, Giannatempo P, Cerbone L, Doni L, Roviello G, Pillozzi S, Antonuzzo L. Gambale E, et al. Among authors: messina c, messina m. Clin Genitourin Cancer. 2024 Aug;22(4):102099. doi: 10.1016/j.clgc.2024.102099. Epub 2024 Apr 24. Clin Genitourin Cancer. 2024. PMID: 38776583 Free article.
Symptom profile, case and symptom clustering, clinical and demographic characteristics of a multicentre cohort of 1297 patients evaluated for Long-COVID.
Floridia M, Giuliano M, Weimer LE, Ciardi MR, Agostoni P, Palange P, Rovere Querini P, Zucco S, Tosato M, Lo Forte A, Bonfanti P, Lacedonia D, Barisione E, Figliozzi S, Andreozzi P, Damiano C, Pricci F, Onder G; I. S. S. Long-COVID Study Group. Floridia M, et al. BMC Med. 2024 Nov 14;22(1):532. doi: 10.1186/s12916-024-03746-9. BMC Med. 2024. PMID: 39543596 Free PMC article.
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey.
Reni M, Giommoni E, Bergamo F, Milella M, Cavanna L, Di Marco MC, Spada M, Cordio S, Aprile G, Cardellino GG, Maiello E, Bernardini I, Ghidini M, Bozzarelli S, Macchini M, Orsi G, De Simone I, Rulli E, Porcu L, Torri V, Pinto C; GARIBALDI Study Group. Reni M, et al. ESMO Open. 2023 Feb;8(1):100777. doi: 10.1016/j.esmoop.2022.100777. Epub 2023 Feb 1. ESMO Open. 2023. PMID: 36731325 Free PMC article.
A Prospective Observational Study on the Structuring Process and Implementation of a Large Regional, Inter-hospital, Virtual Multidisciplinary Tumor Board on Prostate Cancer.
Valerio MR, Serretta V, Arico D, Fazio I, Altieri V, Baldari S, Pennisi M, Girlando A, Spada M, Gesolfo CS, Messina M, Messina C, Giorgia L, Sortino G, DI Grazia A, Guggino R, Borsellino N, Piazza D, Gebbia V. Valerio MR, et al. Among authors: messina c, messina m. Anticancer Res. 2023 Jan;43(1):501-508. doi: 10.21873/anticanres.16187. Anticancer Res. 2023. PMID: 36585190
Frailty index, frailty phenotype and 6-year mortality trends in the FRASNET cohort.
Damanti S, De Lorenzo R, Citterio L, Zagato L, Brioni E, Magnaghi C, Simonini M, Ruggiero MP, Santoro S, Senini E, Messina M, Farina F, Festorazzi C, Vitali G, Manunta P, Manfredi AA, Lanzani C, Rovere-Querini P. Damanti S, et al. Among authors: messina m. Front Med (Lausanne). 2025 Jan 8;11:1465066. doi: 10.3389/fmed.2024.1465066. eCollection 2024. Front Med (Lausanne). 2025. PMID: 39845826 Free PMC article.
1,095 results